Daxor Corporation (DXR:NASDAQ) closed at $9.25 on October 23, 2026, down 1.60% on the day. The stock trades 37.3% below its 52-week high of $14.76 and 8.1% above its 52-week low of $8.56. Over the past year, it lost 32.9%. Daxor Corporation is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, DXR closed higher on 104 days (41%). Its best day was October 28, 2025 (+13.54%) and its worst was October 27, 2025 (-16.91%). The stock moved 10% or more in a single session 2 times.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Find more stocks like DXR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.